Cystic fibrosis transmembrane conductance regulator gene mutations: do they play a role in the aetiology of allergic bronchopulmonary aspergillosis?
- 2 May 2002
- journal article
- research article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 32 (5) , 756-761
- https://doi.org/10.1046/j.1365-2222.2002.01361.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletionJournal of Allergy and Clinical Immunology, 2001
- Increased frequency of cystic fibrosis deltaF508 mutation in bronchiectasis associated with rheumatoid arthritisEuropean Respiratory Journal, 1999
- ΔF508 heterozygosity in cystic fibrosis and susceptibility to asthmaThe Lancet, 1998
- CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types.American Journal of Roentgenology, 1995
- Mutations in the Cystic Fibrosis Gene in Patients with Congenital Absence of the Vas DeferensNew England Journal of Medicine, 1995
- Diagnosis and Management of Allergic Bronchopulmonary AspergillosisAllergy and Asthma Proceedings, 1994
- Mutation Analysis for Heterozygote Detection and the Prenatal Diagnosis of Cystic FibrosisNew England Journal of Medicine, 1990
- Pulmonary abnormalities in obligate heterozygotes for cystic fibrosis.Thorax, 1987
- A familial occurrence of allergic bronchopulmonary aspergillosis: A probable environmental sourceJournal of Allergy and Clinical Immunology, 1985
- A comparison of the prevalence of sensitization to antigens among asthmatics in Cleveland and LondonJournal of Allergy and Clinical Immunology, 1978